![Aarush](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/default-dp.jpg)
Aarush Pandurang
Moderator
United Arab Emirates
![Aarush](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/default-dp.jpg)
Aarush Pandurang ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/ae.png)
Aarush Pandurang
Moderator | INDEX Holdings - UAE**
Moderator
![Ava](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/3nwM5jg4yUQmC3QGkR0DyWa3L9ozoajol4oGbWj6.png)
Ava Kwong
Clinical Professor, Chief of Division of Breast Surgery
Hong Kong
![Ava](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/3nwM5jg4yUQmC3QGkR0DyWa3L9ozoajol4oGbWj6.png)
Ava Kwong ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/hk.png)
Ava Kwong
Clinical Professor, Chief of Division of Breast Surgery | The University of Hong Kong
Professor Ava Kwong is Daniel C K Yu Professor in Breast Cancer Research and Clinical Professor of the Department of Surgery at The University of Hong Kong (HKU), Chief of Division of Breast Surgery at HKU, Queen Mary, Tung Wah and HKU-Shenzhen Hospital. Professor Kwong’s research interests focus on breast and ovarian cancer genetics, advanced surgical technologies and clinical trials in oncological treatment. She has authored chapters in textbooks and has over 280 peer-reviewed publications in reputable journals. She has received numerous grants and awards, including a commissioned grant from The Government of the Hong Kong Special Administrative Region (HKSAR) to study the risk factors of breast cancer and this cooperated study has led to the establishment of the first subsidized risk based breast screening “Breast Cancer Screening Pilot Programme” in Hong Kong. In 2019, She was received Uccio Querci della Rovere Award of BASO~ The Association for Cancer Surgery in United Kingdom. In 2023, she was awarded the HKU Faculty Clinical Service Excellence Awards. Beyond her research, Professor Kwong is active in public and community services. She is the Founder and Chairperson of the Hong Kong Hereditary Breast Cancer Family Registry, a charitable organization. She is also a member of several committees including Cancer Coordinating Committee of the Health Bureau, The Government of HKSAR and Central Committee on Cancer Service of Hospital Authority, Hong Kong.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Elaine](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/hNgFEXG6d1HMnOaFXuiBLuVhbkszPpyDq82apIgp.png)
Elaine Lim
Senior Consultant, Division of Medical Oncology
Singapore
![Elaine](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/hNgFEXG6d1HMnOaFXuiBLuVhbkszPpyDq82apIgp.png)
Elaine Lim ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Elaine Lim
Senior Consultant, Division of Medical Oncology | National Cancer Centre Singapore
Dr Elaine Lim is Senior Consultant, Division of Medical Oncology, National Cancer Centre of Singapore (NCCS); Director, Division of Community Outreach & Philanthropy, NCCS; President, Singapore Society of Oncology; Senior Clinician Scientist, Genome Institute of Singapore; Clinician Researcher, Institute of Molecular & Cell Biology, Singapore. She has continued her laboratory research activities in collaboration with the Genome Institute of Singapore and the Institute of Molecular and Cell Biology, and actively participates in clinical trials. She founded Breast Cancer Research Singapore, a consortium of clinicians and scientists dedicated to basic and translational breast cancer research in Singapore, whose Patron is the President of Singapore, Her Excellency Halimah Yacob. Dr. Lim spearheaded NCCS Home Care, and has contributed to national healthcare financing and policy workgroups set up under the auspices of the Ministry of Health, Singapore.
Lectures by this speaker
Saturday, 2024-07-27
Breaking Barriers: Redefining Treatment Standards in High-Risk Early Breast Cancer with Abemaciclib – Satellite Symposium by DKSH
11:00 - 11:30
![Faye](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/lUEDYhWss9zqQk7Q9cKLuerm6Hs7dP0Z99nJYUC2.png)
Faye Lim
Senior Consultant Radiation Oncologist
Singapore
![Faye](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/lUEDYhWss9zqQk7Q9cKLuerm6Hs7dP0Z99nJYUC2.png)
Faye Lim ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Faye Lim
Senior Consultant Radiation Oncologist | National Cancer Centre
Dr Faye Lim is a Senior Radiation Oncologist at the National Cancer Centre Singapore who specializes in both Breast and Gastrointestinal Cancers. She trained at the Mount Vernon Cancer Centre and the University College London Hospitals in the United Kingdom. She has a special interest in the use and optimization of proton therapy and is the Clinical Lead for proton therapy in the treatment of breast cancer.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
Saturday, 2024-07-27
Making the Case for Proton Beam Therapy in Young Women with Breast Cancer
14:05 - 14:20
![Frances](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/p4Dmi08OLXP6Qh6a5JotWqw5JBIdug2WJtIgMIxu.png)
Frances Que
Medical Oncologist
Philippines
![Frances](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/p4Dmi08OLXP6Qh6a5JotWqw5JBIdug2WJtIgMIxu.png)
Frances Que ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/ph.png)
Frances Que
Medical Oncologist | St Luke’s Medical Center
Dr Frances Victoria Que completed her internal medicine residency and medical oncology fellowship training at St Luke’s Medical Center, Quezon City, Philippines, an observership in cancer genetics at the National University Hospital Singapore, and cancer genomic medicine fellowship training at the National Cancer Center Singapore. She is currently an active consultant for internal medicine, medical oncology, and cancer genetics and genomics at St Luke’s Medical Center Quezon City and Global City, and Makati Medical Center, Philippines.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Hee Jeong](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/xNCpIBLNZAZyaNEox4VKZLBcYDxyruYKKPTE9vHb.png)
Hee Jeong Kim
Breast Cancer Specialist
Korea South
![Hee Jeong](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/xNCpIBLNZAZyaNEox4VKZLBcYDxyruYKKPTE9vHb.png)
Hee Jeong Kim ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/kr.png)
Hee Jeong Kim
Breast Cancer Specialist | Asan Medical Center
A Ph.D. and M.S. graduate of Ulsan University, Prof. Kim Hee Jeong completed her M.D. from Cheon Buk National University. She is currently a Professor at University of Ulsan and previously was a Visiting Doctor at Dana Farber Harvard Medical School (2017-2019) and Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center (2010). She has published the Journal of Clinical Oncology in "Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial" and published 162 SCI and SCIE papers.
Lectures by this speaker
Saturday, 2024-07-27
Bridging the Gap with Oncofertility Care
10:35 - 10:50
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
![Joline](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/nfq3uMHEesr2AezMvjkFWWfSRu4uXTRqTv0kvvD1.png)
Joline Lim
Consultant, Department of Haematology-Oncology
Singapore
![Joline](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/nfq3uMHEesr2AezMvjkFWWfSRu4uXTRqTv0kvvD1.png)
Joline Lim ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Joline Lim
Consultant, Department of Haematology-Oncology | National University Cancer Institute
Dr Joline Lim is a consultant and clinician scientist at the National University Cancer Institute, Singapore. Her primary clinical and research interests are in breast oncology and early phase clinical trials, with a special focus on the development of novel anti-cancer therapeutic agents and biomarkers. Dr Lim has a keen interest in translational research involving novel anti-tumour therapies including molecular targeted agents and immunotherapies, and the application of emerging predictive and pharmacodynamic biomarkers.
Lectures by this speaker
Saturday, 2024-07-27
Fireside chat: Beyond ubiquitous HER2 testing – Making Precision Oncology a Reality for Young Asian Patients
13:35 - 14:05
![Kiley](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/BICcfToZ6IKHRzsH90vBQPvDZBRZgIONNBC1Fhub.png)
Kiley Loh
Medical Oncologist
Malaysia
![Kiley](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/BICcfToZ6IKHRzsH90vBQPvDZBRZgIONNBC1Fhub.png)
Kiley Loh ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/my.png)
Kiley Loh
Medical Oncologist | Penang Adventist Hospital
Dr Kiley Loh is a medical oncologist specializing in treating breast cancers, managing side effects and cancer survivorship. Dr Loh joined Curie Oncology to lead its services in Malaysia at the Penang Adventist Hospital. He continues to subspecialize in breast cancers and remains a visiting consultant with NCCS’ Division of Supportive and Palliative to continue his work in cancer supportive and survivorship care.
Lectures by this speaker
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
![Lim](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/DLQGN3sCooju0w6ZGDFXid0RFIRG7r2WkQ1A982p.png)
Lim Sue Zann
Consultant in Surgical Oncology
Singapore
![Lim](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/DLQGN3sCooju0w6ZGDFXid0RFIRG7r2WkQ1A982p.png)
Lim Sue Zann ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Lim Sue Zann
Consultant in Surgical Oncology | SingHealth Duke-NUS Breast Centre
Dr Lim Sue Zann is a consultant in the Singhealth Duke-NUS Breast Centre. She graduated with honours from the Faculty of Medicine, University of Malaya in 2008. She became a Fellow of the Royal College of Surgeons (Edinburgh) and registered as a specialist in general surgery in 2017. She has also completed the Advanced Breast Surgery Fellowship Programme under Singhealth Duke-NUS Breast Centre and Department of Reconstructive and Aesthetic Surgery, Singapore General Hospital. This fellowship focuses on both oncological and reconstructive breast surgery. In 2022, she underwent surgical training in Asan Medical Center in South Korea focusing on minimally invasive breast surgery. In 2023, she also visited the Royal Marsden Hospital in London to learn new techniques on oncoplastic breast surgery. She is also actively involved in medical education. She received the Dean’s Award for Teaching Excellence from Yong Loo Lin Medical School in 2013. She is also an adjunct assistant professor in DUKE-NUS Medical School. She was appointed as a Physician Faculty Member for SingHealth General Surgery Residency Program in 2018 and now a Core Faculty Member in this programme. She is also the Clinical Core Faculty Member for Post Graduate Year 1 Doctors in the Department of General Surgery Singapore General Hospital. Her research interests are mainly in de-escalation of axillary treatment in breast cancer patient, breast sarcoma and phyllodes tumours. Based on her work in the above topic, she was awarded the Singapore General Hospital Research Grant in 2016.
Lectures by this speaker
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
![Ma](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Ge7Aszc3WKgSC3Yb3DCYAtEnafYvopRjCukCX5Ob.png)
Ma Jun
Medical Oncologist
Singapore
![Ma](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Ge7Aszc3WKgSC3Yb3DCYAtEnafYvopRjCukCX5Ob.png)
Ma Jun ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Ma Jun
Medical Oncologist | Singapore General Hospital
Dr Ma Jun received her undergraduate degree from Monash University, Australia. She trained in Medical Oncology in National Cancer Centre Singapore and is currently specialising in breast cancer treatment. She has a special interest in young women with breast cancer as well as supportive care needs in breast cancer.
Lectures by this speaker
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
Saturday, 2024-07-27
Session 1: Biological and Clinical Uniqueness of Young Asian Breast Cancer
10:05 - 11:30
Saturday, 2024-07-27
Opening Remarks
10:00 - 10:05
![Mastura](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/YY013r1jDyAWcuyK2uNlR3HXVzbm2GJ1tt2bcg0U.png)
Mastura Md Yusof
Cancer Centre Head and Consultant Clinical Oncologist
Malaysia
![Mastura](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/YY013r1jDyAWcuyK2uNlR3HXVzbm2GJ1tt2bcg0U.png)
Mastura Md Yusof ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/my.png)
Mastura Md Yusof
Cancer Centre Head and Consultant Clinical Oncologist | Pantai Hospital Kuala Lumpur
Dr. Mastura Md. Yusof is a Consultant Clinical Oncologist and Head of the Cancer Centre at PICASO Hospital and Pantai Hospital Kuala Lumpur, She leads the research unit at Pantai Hospital Kuala Lumpur, overseeing numerous clinical trials in breast and lung cancer including fundamental trials that resulted in the approval of pembrolizumab in metastatic triple negative breast cancer. She is actively participating in international clinical trials in varied innovative therapies such as targeted therapies, PARP inhibitors, immunotherapies and antibody-drug conjugates and has co-authored numerous peer-reviewed publications in national and international journals.
Lectures by this speaker
Saturday, 2024-07-27
Fireside chat: Beyond ubiquitous HER2 testing – Making Precision Oncology a Reality for Young Asian Patients
13:35 - 14:05
![Matteo](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/jcLx5jjx60aqoffe2yJmgp9QsQNSmsG2r3fOd6mS.png)
Matteo Lambertini
Associate Professor and Consultant in Medical Oncology
Italy
![Matteo](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/jcLx5jjx60aqoffe2yJmgp9QsQNSmsG2r3fOd6mS.png)
Matteo Lambertini ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/it.png)
Matteo Lambertini
Associate Professor and Consultant in Medical Oncology | IRCCS Policlinico San Martino Hospital – University of Genova
Dr. Matteo Lambertini is an associate professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital – University of Genova in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research. Thanks to the support of the European Society for Medical Oncology (ESMO), he has recently completed his PhD at the Universite Libre de Bruxelles (U.L.B.) in Brussels (Belgium) with a project entitled “Unmet Fertility and Pregnancy-related Issues in Young Breast Cancer Patients". He is a member of the guideline group on fertility preservation in cancer patients for the European Society for Medical Oncology (ESMO), the European Society of Human Reproduction and Embriology (ESHRE) and the Italian Association of Medical Oncology (AIOM).
Lectures by this speaker
Saturday, 2024-07-27
Addressing the Unique Needs of Young Women with Breast Cancer: A Call for Comprehensive Care
10:05 - 10:20
![Muhammad](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/EwlxX7i7vm07aMIADKrOflpxlR3cXOaZiofD3ZOu.png)
Muhammad Azrif
Consultant Clinical Oncologist
Malaysia
![Muhammad](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/EwlxX7i7vm07aMIADKrOflpxlR3cXOaZiofD3ZOu.png)
Muhammad Azrif ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/my.png)
Muhammad Azrif
Consultant Clinical Oncologist | Prince Court Medical Centre
Dr. Muhammad Azrif graduated from the Royal Free Hospital & University College London School of Medicine, London, UK in 1997. After completing his training in internal medicine and obtaining his MRCP (UK) in 2000, he entered the specialist training program in Clinical Oncology at the Christie Hospital, Manchester, UK. He became a Fellow of the Royal College of Radiologists (Clinical Oncology) in 2005 and attained his Certificate of Completion of Specialist Training (UK) before admission to the UK General Medical Council Specialist Register in 2006. He was awarded a one-year Clinical Research Fellowship to the Department of Radiation Oncology, University of Toronto, Canada in mid-2006. He returned to Malaysia in 2007 and served at the National University of Malaysia Medical Centre (UKMMC) as a Consultant Clinical Oncologist for 5 years before joining private practice in 2012. He has served on various national oncology committees, published in peer-reviewed journals as well as participated in numerous clinical trials, cancer advisory boards, and expert panels.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Nur Diana](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/ctfX5RCPZAuPLLYZjG0nDArcCDfOvgzSngLBDDHn.png)
Nur Diana Ishak
Genetic Counsellor
Singapore
![Nur Diana](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/ctfX5RCPZAuPLLYZjG0nDArcCDfOvgzSngLBDDHn.png)
Nur Diana Ishak ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Nur Diana Ishak
Genetic Counsellor | National Cancer Centre
Diana is a genetic counsellor with the Cancer Genetics Service at the National Cancer Centre Singapore. Beyond her clinical role, Diana is passionate about public education and outreach, actively engaging with support groups and fostering greater patient awareness and support across diverse communities.
Lectures by this speaker
Saturday, 2024-07-27
Genetic Testing in an Ethnically Diverse Asian Country
11:30 - 11:45
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Sabrina](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/COA4DEaXAG2PQu1VhEItSuFaxCiIUdRVijMkNNki.png)
Sabrina Ngaserin
Head of Breast Surgery
Singapore
![Sabrina](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/COA4DEaXAG2PQu1VhEItSuFaxCiIUdRVijMkNNki.png)
Sabrina Ngaserin ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Sabrina Ngaserin
Head of Breast Surgery | Sengkang General Hospital, SingHealth Duke-NUS Breast Centre, Singapore
Assistant Professor Sabrina Ngaserin is Head of Breast Surgery at Sengkang General Hospital (SKH), SingHealth Duke-NUS Breast Centre, Assistant Professor of Duke-NUS Post-graduate Medical School and Yong Loo Lin School of Medicine, National University of Singapore, Physician Faculty with SingHealth’s General Surgery Residency Program, and Programme Director of the SKH Advanced Breast Surgery (Oncoplastic and Minimally Invasive) Fellowship programme. Formally trained in oncoplastic breast surgery, minimally invasive and endoscopic breast surgery, her main interest lies in cutting edge breast cancer surgical techniques that considers the patients oncological safety alongside their need for aesthetic, quality of life and function preserving solutions
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Samuel](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/S1ptxCXAoGjMveewd5N6dJFtzOjUPqmytyjSPhuX.png)
Samuel Ow
Senior Consultant Medical Oncologist
Singapore
![Samuel](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/S1ptxCXAoGjMveewd5N6dJFtzOjUPqmytyjSPhuX.png)
Samuel Ow ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Samuel Ow
Senior Consultant Medical Oncologist | National University Cancer Institute
Dr. Samuel Ow is Senior Consultant Medical Oncologist and Clinical Director at the Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS). His clinical and research interests are in Breast Cancer and Clinical Cancer Genetics. He sits on the committee for the Breast Cancer Awareness Campaign at the institutional and national level, to help drive greater awareness for breast cancer screening and prevention in the general public.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Sara](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/mTznhZOqPQgP7TbNKXcoKko1i4xr1YnkfQyWoDVe.png)
Sara Tolaney
Chief, Division of Breast Oncology / Associate Professor of Medicine
USA
![Sara](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/mTznhZOqPQgP7TbNKXcoKko1i4xr1YnkfQyWoDVe.png)
Sara Tolaney ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/us.png)
Sara Tolaney
Chief, Division of Breast Oncology / Associate Professor of Medicine | Dana-Farber Cancer Institute / Harvard Medical School
Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on the development of novel therapies in the treatment of breast cancer.
Lectures by this speaker
Saturday, 2024-07-27
Incorporating Novel Therapies in Neo(Adj) therapies for Young Women with Breast Cancer, Immunotherapy, Antibody drug conjugates and more
14:20 - 14:35
![Stephen](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/ib5F3o91z8rzbqvacwCOzlv0jYeCjhVm3DiFkamS.png)
Stephen Johnston
Professor of Breast Cancer Medicine and Consultant Medical Oncologist
United Kingdom
![Stephen](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/ib5F3o91z8rzbqvacwCOzlv0jYeCjhVm3DiFkamS.png)
Stephen Johnston ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/gb.png)
Stephen Johnston
Professor of Breast Cancer Medicine and Consultant Medical Oncologist | The Royal Marsden NHS Foundation Trust
Stephen Johnston is a Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. He is currently a Clinical Director of the Breast, Lung and AOS Clinical Business Unit at The Royal Marsden. He has published over 250 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national and international meetings.
Lectures by this speaker
Saturday, 2024-07-27
Breaking Barriers: Redefining Treatment Standards in High-Risk Early Breast Cancer with Abemaciclib – Satellite Symposium by DKSH
11:00 - 11:30
![Thitiya](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/R5OedkWWZSNEVOPgTy8JP6GdO2y40ygy7pKsnMnp.png)
Thitiya Sirisinha Dejthevaporn
Assistant Professor, Division of Medical Oncology
Thailand
![Thitiya](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/R5OedkWWZSNEVOPgTy8JP6GdO2y40ygy7pKsnMnp.png)
Thitiya Sirisinha Dejthevaporn ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/th.png)
Thitiya Sirisinha Dejthevaporn
Assistant Professor, Division of Medical Oncology | Ramathibodi Hospital, Mahidol University, Bangkok
Dr Thitiya Dejthevaporn is Assistant Professor at the Medical Oncology Unit, Department of Internal Medicine, Ramathibodi Hospital, in Bangkok, Thailand. She obtained her Doctor of Medicine (First Degree Honor) from the Mahidol University in 1991, and completed both her residency in Internal Medicine and Fellowship training in Hematology and Medical Oncology at the University of Alabama, Birmingham, USA. Dr Dejthevaporn has special interest in breast cancer, GU cancer, brain tumor and palliative care. She has conducted clinical research in treatment of various malignancies including breast and lung cancer. She has also contributed to the development of National Practice Guidelines for breast, gastric and esophageal cancers with the National Health Security Office and National Cancer Institute. She is currently a vice president of the Thai Society of Clinical Oncology and Head of Medical Oncology Unit at Ramathibodi Hospital, Mahidol University.
Lectures by this speaker
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
![Timothy](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/7gsFlS4lDs5pRtwbyyoIDCTNzlOJD5JxHqiKtF01.png)
Timothy Tay
Senior Consultant Pathologist
Singapore
![Timothy](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/7gsFlS4lDs5pRtwbyyoIDCTNzlOJD5JxHqiKtF01.png)
Timothy Tay ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Timothy Tay
Senior Consultant Pathologist | Singapore General Hospital
Dr. Timothy graduated from Yong Loo Lin School of Medicine, National University of Singapore and did his postgraduate residency training in Anatomical Pathology. Having completed his fellowship exams, he is a Fellow of both The Royal College of Pathologists (United Kingdom) as well as The Royal College of Pathologists of Australasia. He has a special interest in Breast, Bone and Soft Tissue and Molecular Pathology and was awarded the SingHealth Health Manpower Development Plan (HMDP) Fellowship to pursue further training at the Memorial Sloan Kettering Cancer Centre in New York, USA as well as Institute of Pathology, Heidelberg University Hospital, Germany. Timothy currently holds a Senior Consultant position at the Singapore General Hospital Department of Anatomical Pathology within which he also heads the Anatomical Molecular Laboratory (former Translational Pathology Centre).
Lectures by this speaker
Saturday, 2024-07-27
Fireside chat: Beyond ubiquitous HER2 testing – Making Precision Oncology a Reality for Young Asian Patients
13:35 - 14:05
![Tira](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Lcxgc94LgPqm2lPpe16CL6zEb47atRHe4ETP2v39.png)
Tira Tan
Consultant Medical Oncologist
Singapore
![Tira](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Lcxgc94LgPqm2lPpe16CL6zEb47atRHe4ETP2v39.png)
Tira Tan ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Tira Tan
Consultant Medical Oncologist | National Cancer Centre Singapore
Dr Tira Tan is a consultant medical oncologist at the National Cancer Centre Singapore with a clinical focus in the treatment of breast cancers and early phase drug development. Dr Tan chairs the pre-operative and young women’s breast cancer programs at NCCS and is the divisional deputy director of research as well as a primary and co-investigator on many early and late phase studies specifically in novel therapeutics and treatment strategies in triple negative breast cancer.
Lectures by this speaker
Saturday, 2024-07-27
Session 3: State of the Art Therapies in Young Women
12:55 - 14:50
![Tom](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/b6MPM4r4HlJkwzMK4WiyFVyZMH6BYDdMt0ENVr0U.png)
Tom Chen
Attending Physician, Department of Oncology
Taiwan (province of China)
![Tom](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/b6MPM4r4HlJkwzMK4WiyFVyZMH6BYDdMt0ENVr0U.png)
Tom Chen ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/tw.png)
Tom Chen
Attending Physician, Department of Oncology | National Taiwan University Hospital
Dr. Tom W. Chen is currently an attending physician at the Department of Oncology, National Taiwan University Hospital (NTUH) and National Taiwan University Cancer Center in Taipei, Taiwan. Dr. Chen received internal medicine training followed by a fellowship course as a medical oncologist in NTUH. Afterwards, he joined Drug Development Program (DDP) in Princess Margaret Cancer Centre in Toronto, Canada as a clinical fellow to study early phase clinical trials with Dr. Lillian Siu and Dr. Phil Bedard. During his stay in Princess Margaret, he gained more experience with next-generation sequencing and precision medicine, as well as interest in breast cancer patients. After returning to NTUH, he joined in NTUH breast cancer team and was invovled in various clinical trials including the bevacizumab, cisplatin, and etoposide (the BEEP) regimen in brain cancer patients with brain metastases, the ESR1 mutation landscape in Asian ER+/HER2- metastatic patients, and the combination of lapatinib and vinorelbine in HER2+ MBC.. His publications included studies regarding the thromboembolism events of tamoxifen in Asian population, HER2 treatment reviews, and next-generation sequecing studies in breast cancer. Besides breast cancer, he is also involved in sarcoma and phase I drug development studies.
Lectures by this speaker
Saturday, 2024-07-27
Tumor Board: Hereditary Cancer Syndromes beyond BRCA – Li Fraumeni / Cowden’s
12:00 - 12:40
![Yang](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/wZHrtvlgyTxqG5iETOdkwhRHeARHLXp7oanF5qZG.png)
Yang Liying
Senior Consultant
Singapore
![Yang](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/wZHrtvlgyTxqG5iETOdkwhRHeARHLXp7oanF5qZG.png)
Yang Liying ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Yang Liying
Senior Consultant | Singhealth
Dr Yang Liying is a Consultant in the Department of Obstetrics & Gynaecology. She graduated from the Yong Loo Lin School of Medicine of the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2008. She completed her Master of Medicine in Obstetrics & Gynaecology in 2013 and became a Member of the Royal College of Obstetrics & Gynaecology in the same year. She gained accreditation as a specialist in Obstetrics & Gynaecology in 2016 and obtained her Masters in Medical Genetics in 2021. She is also an International Board-Certified Lactation Consultant (IBCLC). Dr Yang brings an evidence-based and patient-centric approach to clinical care. Her sub-specialty interests are in Maternal-Fetal Medicine, Prenatal Genetics and Breastfeeding Medicine, as she believes that pregnancy is a unique opportunity to provide quality care that can influence the long-term health of the family, mother and child.
Lectures by this speaker
Saturday, 2024-07-27
Panel Discussion: A case of pregnancy associated breast cancer
12:55 - 13:35
![Yap Yoon](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/yNPzFGBOgWiC7XknixRbtCZTv45eOn7V8Aqb7hUl.png)
Yap Yoon Sim
Senior Consultant
Singapore
![Yap Yoon](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/yNPzFGBOgWiC7XknixRbtCZTv45eOn7V8Aqb7hUl.png)
Yap Yoon Sim ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Yap Yoon Sim
Senior Consultant | National Cancer Centre Singapore
Dr. Yap is Senior Consultant in the Division of Medical Oncology at the National Cancer Centre Singapore, and Associate Professor at Duke-National University Singapore. A recipient of the Singapore National Medical Research Council (NMRC) Clinician Scientist Award (CSA), her research focuses primarily on clinical and translational research in breast cancer, including liquid biopsies and predictive biomarkers, development of novel therapeutic strategies, and epidemiologic studies on treatment outcomes in breast cancer. She is the principal investigator of several phase 1 to 3 clinical trials for various compounds, including CDK inhibitors, PI3K and mTOR inhibitors, selective estrogen receptor degraders, HER2-targeting agents and immunotherapy, in addition to investigator-initiated studies.
Lectures by this speaker
Saturday, 2024-07-27
Racial and Ethnic Disparities in Breast Cancer Outcomes for Young Women
10:20 - 10:35
![Zhang](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Ulh1tg7Sc3LUrwqir8uaMxpGh5b7FMW8cd2qZLRb.png)
Zhang Zewen
Medical Oncologist
Singapore
![Zhang](https://index-s3-images-static-content.s3.eu-west-1.amazonaws.com/images/speakers/Ulh1tg7Sc3LUrwqir8uaMxpGh5b7FMW8cd2qZLRb.png)
Zhang Zewen ![Flag](https://ywforum.com/wp-content/plugins/maestro/assets/images/countries/100/sg.png)
Zhang Zewen
Medical Oncologist | National Cancer Centre Singapore
Dr Zhang Zewen is a Medical Oncologist in NCCS sub-specializing in Breast cancer and Gynecological cancer. He has a special interest in Cancer Genetics, and is part of the Cancer Genetics Service team involved in research related to hereditary cancer predisposition syndromes, including Hereditary Breast and Ovarian Cancer and Lynch syndrome.